These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 20479417)

  • 21. Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients.
    Pan E; Pellarin M; Holmes E; Smirnov I; Misra A; Eberhart CG; Burger PC; Biegel JA; Feuerstein BG
    Clin Cancer Res; 2005 Jul; 11(13):4733-40. PubMed ID: 16000568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Large cell/anaplastic" medulloblastomas: a Pediatric Oncology Group Study.
    Brown HG; Kepner JL; Perlman EJ; Friedman HS; Strother DR; Duffner PK; Kun LE; Goldthwaite PT; Burger PC
    J Neuropathol Exp Neurol; 2000 Oct; 59(10):857-65. PubMed ID: 11079775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of single-copy chromosome 17q gain in human neuroblastomas using real-time quantitative polymerase chain reaction.
    Morowitz M; Shusterman S; Mosse Y; Hii G; Winter CL; Khazi D; Wang Q; King R; Maris JM
    Mod Pathol; 2003 Dec; 16(12):1248-56. PubMed ID: 14681326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Detection of chromosomal DNA imbalance in medulloblastoma by comparative genomic hybridization].
    Sun YJ; Yu SZ; Sun CY; Wang Q; Jin SM; Wu WX; An TL
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):606-10. PubMed ID: 21092588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort.
    Pietsch T; Schmidt R; Remke M; Korshunov A; Hovestadt V; Jones DT; Felsberg J; Kaulich K; Goschzik T; Kool M; Northcott PA; von Hoff K; von Bueren AO; Friedrich C; Mynarek M; Skladny H; Fleischhack G; Taylor MD; Cremer F; Lichter P; Faldum A; Reifenberger G; Rutkowski S; Pfister SM
    Acta Neuropathol; 2014 Jul; 128(1):137-49. PubMed ID: 24791927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular stratification of medulloblastoma: comparison of histological and genetic methods to detect Wnt activated tumours.
    Goschzik T; Zur Mühlen A; Kristiansen G; Haberler C; Stefanits H; Friedrich C; von Hoff K; Rutkowski S; Pfister SM; Pietsch T
    Neuropathol Appl Neurobiol; 2015 Feb; 41(2):135-44. PubMed ID: 24894640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of genetic and chromosomal aberrations in medulloblastomas and primitive neuroectodermal tumors with DNA microarrays.
    Kagawa N; Maruno M; Suzuki T; Hashiba T; Hashimoto N; Izumoto S; Yoshimine T
    Brain Tumor Pathol; 2006 Apr; 23(1):41-7. PubMed ID: 18095118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of 10q26.1-q26.3 in association with 7q34-q36.3 gain or 17q24.3-q25.3 gain predict poor outcome in pediatric medulloblastoma.
    Pezzolo A; Coco S; Raso A; Parodi F; Pistorio A; Valdora F; Capra V; Zollo M; Aschero S; Basso E; Cama A; Nozza P; Gambini C; Cinalli G; Garrè ML; Iolascon A; Pistoia V; Tonini GP
    Cancer Lett; 2011 Sep; 308(2):215-24. PubMed ID: 21652146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overlay analysis of the oligonucleotide array gene expression profiles and copy number abnormalities as determined by array comparative genomic hybridization in medulloblastomas.
    Lo KC; Rossi MR; Burkhardt T; Pomeroy SL; Cowell JK
    Genes Chromosomes Cancer; 2007 Jan; 46(1):53-66. PubMed ID: 17044047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
    Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
    Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma.
    Ryan SL; Schwalbe EC; Cole M; Lu Y; Lusher ME; Megahed H; O'Toole K; Nicholson SL; Bognar L; Garami M; Hauser P; Korshunov A; Pfister SM; Williamson D; Taylor RE; Ellison DW; Bailey S; Clifford SC
    Acta Neuropathol; 2012 Apr; 123(4):501-13. PubMed ID: 22139329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel amplifications in pediatric medulloblastoma identified by genome-wide copy number profiling.
    Nord H; Pfeifer S; Nilsson P; Sandgren J; Popova S; Strömberg B; Alafuzoff I; Nistér M; Díaz de Ståhl T
    J Neurooncol; 2012 Mar; 107(1):37-49. PubMed ID: 21979893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metaphase and array comparative genomic hybridization: unique copy number changes and gene amplification of medulloblastomas in South America.
    Yoshimoto M; Bayani J; Nuin PA; Silva NS; Cavalheiro S; Stavale JN; Andrade JA; Zielenska M; Squire JA; de Toledo SR
    Cancer Genet Cytogenet; 2006 Oct; 170(1):40-7. PubMed ID: 16965953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gain of 1q is a potential univariate negative prognostic marker for survival in medulloblastoma.
    Lo KC; Ma C; Bundy BN; Pomeroy SL; Eberhart CG; Cowell JK
    Clin Cancer Res; 2007 Dec; 13(23):7022-8. PubMed ID: 18056178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies.
    Schwalbe EC; Williamson D; Lindsey JC; Hamilton D; Ryan SL; Megahed H; Garami M; Hauser P; Dembowska-Baginska B; Perek D; Northcott PA; Taylor MD; Taylor RE; Ellison DW; Bailey S; Clifford SC
    Acta Neuropathol; 2013 Mar; 125(3):359-71. PubMed ID: 23291781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma.
    Park AK; Lee JY; Cheong H; Ramaswamy V; Park SH; Kool M; Phi JH; Choi SA; Cavalli F; Taylor MD; Kim SK
    BMC Cancer; 2019 Jun; 19(1):571. PubMed ID: 31185958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.
    Bayani J; Zielenska M; Marrano P; Kwan Ng Y; Taylor MD; Jay V; Rutka JT; Squire JA
    J Neurosurg; 2000 Sep; 93(3):437-48. PubMed ID: 10969942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma.
    Chen QR; Bilke S; Wei JS; Whiteford CC; Cenacchi N; Krasnoselsky AL; Greer BT; Son CG; Westermann F; Berthold F; Schwab M; Catchpoole D; Khan J
    BMC Genomics; 2004 Sep; 5():70. PubMed ID: 15380028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinicopathologic significance of β-catenin protein and loss of heterozygosity on 10q in medulloblastoma].
    Li JZ; Wang CH; Zhou FA; Miao N; Abulajang G; Zhang W
    Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):823-7. PubMed ID: 23324231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome wide copy number abnormalities in pediatric medulloblastomas as assessed by array comparative genome hybridization.
    Lo KC; Rossi MR; Eberhart CG; Cowell JK
    Brain Pathol; 2007 Jul; 17(3):282-96. PubMed ID: 17465989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.